StonvexLoading…
StonvexStonvexStonvexCore line items from INVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $112.63M | $97.99M | $411.33M | $296.71M | $188.91M |
Operating Income | Not available | $38.15M | $163.75M | $124.76M | $90.18M |
Net Income | Not available | $186.59M | $271.17M | $107.01M | $63.69M |
EPS (Diluted) | $0.40 | $2.22 | $3.30 | $1.35 | $0.24 |
Total Assets | Not available | $1.84B | $1.64B | $1.43B | $1.33B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $603.09M | $550.94M | $476.51M | $397.53M |
Free Cash Flow OCF − CapEx | Not available | $34.79M | $195.80M | $141.30M | Not available |
Shares Outstanding | Not available | 73.81M | 74.64M | 74.77M | 63.01M |